共 50 条
Improving informed consent in clinical trials: A duty to experiment
被引:63
|作者:
Lavori, PW
Sugarman, J
Hays, MT
Feussner, JR
机构:
[1] Palo Alto VAHCS, Dept Vet Affairs, Cooperat Studies Program Coordinating Ctr, Palo Alto, CA USA
[2] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Div Biostat, Stanford, CA 94305 USA
[3] Palo Alto VAHCS, Nucl Med Serv, Palo Alto, CA USA
[4] Duke Univ, Med Ctr, Durham VAMC, Div Gen Internal Med, Durham, NC USA
[5] Duke Univ, Dept Philosophy, Durham, NC USA
[6] Duke Univ, Dept Vet Affairs, Off Res & Dev, Durham, NC USA
来源:
CONTROLLED CLINICAL TRIALS
|
1999年
/
20卷
/
02期
关键词:
informed consent;
randomized clinical trials;
ethics;
research ethics;
D O I:
10.1016/S0197-2456(98)00064-6
中图分类号:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号:
1001 ;
摘要:
Practitioners of clinical trials have a responsibility to ensure that patients' participation in research be informed and voluntary. This responsibility implies that we should strive continuously to improve the effectiveness of methods for informing prospective research volunteers about experimental studies, thereby enhancing the protection of their interests. We should test innovations in informed consent in realistic contexts (i.e., in clinical trials) and with randomization when it is appropriate, at the first opportunity. In this study, we develop a preliminary proposal to improve the quality of informed consent, based on experimentation with informed consent in ongoing clinical trials. We discuss the conceptual, ethical, organizational, and technical bases for such an effort. Controlled Clin Trials 1999;20:187-193. (C) Elsevier Science Inc. 1999.
引用
收藏
页码:187 / 193
页数:7
相关论文